An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone online asked for a dosing check after starting a new provider who prescribed a mix of peptide injections. The person listed doses for four things: MOTS‑C, CJC‑Ipamorelin (written as CJC/Ipa), and kisspeptin, with MOTS‑C increasing to a higher dose after the first vial. They’re asking the community for feedback on whether those amounts and the schedule make sense. MOTS‑C is a tiny protein that comes from mitochondria, the cell’s energy factories. It’s not a household-name drug — researchers are still studying it — but in simple terms it’s being explored for effects on metabolism, like how cells burn fuel. CJC‑1295 combined with ipamorelin (often shortened to “CJC/Ipa”) is a pair that aims to boost growth‑hormone pulses; CJC‑1295 is a molecule that stimulates the body to release growth hormone–releasing hormone, and ipamorelin mimics another signal that makes the body release growth hormone. Kisspeptin is a separate peptide that impacts reproductive hormone signaling. None of these are routine over‑the‑counter treatments; they’re mainly used experimentally or in specialized clinics. What the post actually shows is a personal prescription plan, not a scientific study. It’s a single person sharing doses: MOTS‑C at 500 micrograms per day ramping to 1000 mcg per injection later, CJC/Ipamorelin 500 mcg per day Monday–Friday, and kisspeptin 250 mcg on Monday/Wednesday/Friday. There’s no data about outcomes, safety monitoring, lab tests, or why those exact numbers were chosen. That means we can’t judge effectiveness or safety from this message. It’s also unclear whether the vials are reconstituted and stored correctly, how injections are rotated, or whether the provider is following any published protocols. Why this might matter is straightforward: people pursue these “stacks” hoping for benefits like better metabolism, body composition, or hormone balance. If someone is considering a similar regimen, they should know that peptides can have meaningful biological effects and sometimes interactions. A dosing plan for one person may be inappropriate for another because of differences in health history, other medications, age, and lab results. Anyone thinking about starting peptide injections should want a clear rationale from their provider, baseline blood tests, and a plan for follow‑up and monitoring. Important caveats: these peptides are not all approved drugs for the uses people pursue, and the clinical evidence is limited. Side effects can include injection‑site reactions, changes in blood sugar, hormonal shifts, or unknown longer‑term risks. Dosage units like micrograms (mcg) are small and easy to mishandle; errors in reconstitution or dosing can cause problems. Pregnant or breastfeeding people, people with certain cancers, or those with uncontrolled chronic disease should be especially cautious. Finally, because this is a single person’s prescription with no reported outcomes, it’s not medical advice; discuss specifics with a licensed healthcare provider who can tailor monitoring and testing to your situation. Bottom line: it’s an individualized, experimental peptide stack rather than evidence‑backed therapy, so proceed only with informed medical oversight and proper safety checks.
Source: r/Peptides